View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

Synthesis

We have manufactured a wide offer for multiple therapeutic areas for human and animal health.

We have manufactured a wide offer for multiple therapeutic areas for human and animal health.

As of today, our synthesis API portfolio counts 58 references, covering Cardiovascular diseases, Metabolic disorders, Analgesics & NSAIDs (non-fluorinated glucocorticoids and derivatives), Central nervous system disorders and Anesthetics.

Commercial and External Partnership, Industrial Affairs (CEPiA) works within the Industrial Affairs sector of Sanofi to help third party acitivites.
Within Sanofi Industrial Affairs, we can offer external partners looking for a CDMO / CMO (contract dupt and manufacturing organisation / contract manufacturing organisation) the...
This paper will discuss the aspects of bioburden reduction in a manufacturing area or cleanroom during operational shutdown or for routine maintenance scheduling.
This white paper showcases Sanofi Active Ingredient Solution's product list for 2018.
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology